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ABSTRACT 
 
Pano, G. (2014). Physical activity benefits for Alzheimer's disease patients. (A Review). J. Hum. Sport 
Exerc., 9(Proc1), pp.S319-S325. Alzheimer's disease (AD) is a chronic and degenerative disease which is 
the main cause for dementia in older adults. It is well known that exercise can reduce the risk level for 
vascular risk factors, heart diseases (Blair et al., 1996), atherosclerosis (Lakka et al., 2001), stroke (Kurl et 
al., 2001) and diabetes (Seals et al., 1984; Houmard et al., 1996), diseases that can increase the risk for 
dementia and AD (Gustafson et al., 2003). Main objective of this study was to review the latest literature 
recomendations regarding the most appropriate exercise testing, programming and types of physical 
activity that Alzheimer’s disease patients should practice. The search has been made mainly, focusing in 
PubMed/MEDLINE, for randomized controlled trial studies which used PA intervention as a weapon for 
delaying or treating symtoms of AD patients. There are clear evidences which shows that AD patients can 
benefit from all types of occupational PA and have a positive effect on their psycho-social and cognitive 
functioning. AD patients who engage in PA, also have positive effect in motor abilities, activities of daily life 
and makes them more independent from others. Further studies for AD patients involving a larger number 
of subjects and different types of individualised exercise interventional programs are necessary to be 
conducted. Key words: ALZHEIMER DISEASE, PHYSICAL ACTIVITY, EXERCISE THERAPY. 
 
                                                
1 Corresponding author. Sports University of Tirana, Sports Sciences Research Institute, Tirana, Albania. 
 E-mail: gentip2005@hotmail.com 
 8th INSHS International Christmas Sport Scientific Conference, 5-7 December 2013. International Network of Sport and 
Health Science. Szombathely, Hungary. 
 JOURNAL OF HUMAN SPORT & EXERCISE ISSN 1988-5202  
 © Faculty of Education. University of Alicante 
 doi:10.14198/jhse.2014.9.Proc1.15 
Proceeding 
Pano / Physical activity benefits for Alzheimer's disease patients. (A Review)          JOURNAL OF HUMAN SPORT & EXERCISE 
S320 | 2014 | Proc1 | VOLUME 9                                                                                        © 2014 University of Alicante 
 
INTRODUCTION 
 
Alzheimer's Disease 
Alzheimer's disease (AD) it’s a chronic and degenerative disease which is the main cause for dementia in 
older adults. The disease was first recognized in 1907 by the German psychiatrist Alois Alzheimer. The 
prevalence of Alzheimer's disease rises exponentially with age. After age 65, the percentage of affected 
people approximately doubles with every decade of life. The highest rate of Alzheimer's disease occurs in 
people age 85 and over. Alzheimer's disease is more common in women than in men. Aging brings an 
increased incidence of cognitive and physical decline, especially in those in the eighth decade and beyond 
(NIA, 2007) Evidences indicates that aging is accompanied by a systematic decline in performance of a 
wide variety of cognitive tasks, observed both in the laboratory setting and in everyday life (Dixon et al., 
2004). Several studies have suggested that differential susceptibility to age-related cognitive decline or to 
Alzheimer’s disease is related to variables such as occupation (Schooler et al., 1999), professional or 
leisure activities (Wilson et al., 2002), and lifestyle (Fillit et al., 2002). A recent Mayo Clinic special report 
(Mayo Clinic Health information) on how exercise helps Alzheimer’s patient’s stated specific benefits, in 
addition to the general ones of improved strength, endurance, cardiovascular health, blood pressure 
control, and reduced risk of falling. At the present time, there is no cure for this disease and, for the most 
part, treatment has been limited. 
 
Some of Alzheimer’s disease symptoms include: 
• Deterioration of language and perception, 
• Judgment problems that compromise the person's ability to carry out activities of daily living, and 
• Behavioral problems such as agitation and paranoia 
• Although the life expectancy among persons with AD is diverse, early mortality is seen among 
persons who develop it early in life and in men 
• However, persons with AD can often live far years with this condition, dying eventually from 
pneumonia or other diseases 
• The duration of Alzheimer's disease from time of diagnosis to death can be 20 years or more, with 
the average length 4 to 8 years 
 
Exercise appears to stimulate neurogenesis (Van Praag et al., 1999), enhance neuronal survival (Barde, 
1994), increase resistance to brain insults (Stummer et al., 1994; Carro et al., 2001) and increase synaptic 
plasticity (Lu & Chow, 1999). 
 
Objectives 
• Main objective of this study was to review the literature of the last five years, regarding the most 
appropriate exercise testing, programming and type of physical activity that Alzheimer’s disease 
patients should be involved. 
• The search has been made mainly, focusing in PubMed/MEDLINE, for randomized controlled trial 
studies which used PA intervention as a weapon for delaying or treating symptoms of AD patients. 
 
Selecting criteria: 
• Only randomized controlled trials studies. 
• Subjects over 55 years old 
• Subjects diagnosed with AD (Males & Females) 
• Only publications in English language. 
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• Subjects that used in the same time other medication treatments for physical and/or psychological 
problems. 
 
RESULTS 
 
Description of the studies: 
From 71 possible papers, only 5 were identified as appropriate to be enrolled in this review.  
 
Enrolled studies were: 
1. Sharon M.A., 2003; 
2. Williams C. L., et al 2008; 
3. Cyarto E.V et al., 2010; 
4. Baker L.D et al., 2010 
5. Vidoni E.D et al., 2012. 
 
Therapeutic regimens were from 2 weeks to 26 months and in all the studies exercise therapy was 
combined with other adjuvant therapies. All the Studies had a total of over 350 participants. 
 
Subject’s age was from 55 years old to 91 years old, also the main used exercise therapies were:  
• Exercise therapy; aerobic exercises/150 min/week, walking on treadmill, 
• Exercise in home conditions 150 min/week, moderate intensity 
• Exercise sessions, flexibility, balance, aerobics and resistance training with weights. 
 
In Sharon MA, 2003 study, 24 individuals, aged 54 to 88 were recruited. They participated from for two to 
eight semesters in program consisted in 16 to 20 exercise sessions and 10 community activity sessions per 
semester. Half of the weekly exercise sessions included memory and language stimulation activities. 
Students, supplemented by family caregivers, supervised the sessions. Exercise sessions consisted of 
flexibility, balance, aerobic, and weight resistance activities. Pre-participation and semiannual post-testing 
of aerobic fitness and duration and upper and lower body strength was done. Highly significant fitness 
gains (p < .001) were achieved in the six-minute walk test, upper and lower body strength, and duration of 
aerobic exercise. Five participants aged 86 to 91, completed six to eight semesters and were doing 27 to 
45 minutes of aerobics per session at program’s end. Five participants scored within the normal range for 
age-matched healthy active adults on the six minute walk test at baseline. Nine others achieved and three 
exceeded the normal range during treatment. 
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Table 1. Interventions characteristics. 
 
 
 
Cognitive decline was slowed and mood improved. Williams et al., 2008 study, was a three-group, 
repeated-measures design with random assignment to treatment group. Forty-five nursing home residents 
with moderate to severe AD were randomly assigned to a 16-week program of comprehensive exercise, 
supervised walking or social conversation. The purpose of this study was to compare the effects of 16 
weeks of a comprehensive exercise routine to supervised walking and social conversation on depression in 
nursing home residents with Alzheimer’s disease (AD). Major outcome variables were depression 
measured by the Cornell Scale for Depression in Dementia, mood measured by the Dementia Mood 
Assessment Scale and the Alzheimer’s Mood Scale, and affect measured by the Observed Affect Scale. 
Results have shown that depression was reduced in all three groups with some evidence of superior 
benefit from exercise. Cyarto et al., (2010) study 230 community-dwelling participants diagnosed with 
Alzheimer’s disease were recruited. Participants were randomly separated into two treatment groups: usual 
care group or 24-week home based program consisting of 150 minutes per week of tailored moderate 
physical activity. The primary outcome measure of this study was cognitive decline as measured by the 
change from baseline in the total score on the Alzheimer’s disease Assessment Scale-Cognitive section. 
Secondary outcomes of interest had included behavioural and psychological symptoms, quality of life, 
functional level, career burden and physical function (strength, balance, endurance, physical activity). 
Primary endpoints were measured at six and twelve months following the baseline assessment. Baker et 
al., 2010 study was a randomized controlled design, were twenty-eight adults (57–83 y old) meeting 2-h 
tolerance test criteria for glucose intolerance completed 6 months of aerobic exercise or stretching, which 
served as the control. The primary cognitive outcomes of this paper included measures of executive 
function (Trails B, Task Switching, Stroop, Self-ordered Pointing Test, and Verbal Fluency). Other 
outcomes included were; memory performance (Story Recall, List Learning), measures of cardio-
respiratory fitness (obtained via maximal-graded exercise treadmill test), glucose disposal during hyper-
insulinemic-euglycemic clamp, body fat, and fasting plasma levels of insulin, cortisol, brain-derived 
neurotrophic factor, insulin-like growth factor-1, amyloid-β (Aβ40 and Aβ42). Vidoni et al., (2012) paper 
porpoise was to report the protocol of a current, community-based pilot study of aerobic exercise for AD to 
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guide future investigation. This manuscript provides 1) an overview of possible benefits of exercise in those 
with dementia, 2) a rationale and recommendations for implementation of a community-based approach, 3) 
recommendation for implementation of similar study protocols, and 4) unique challenges in conducting an 
exercise trial in AD. 
 
DISCUSSION 
 
It remains uncertain how exercise may benefit brain health and cognitive function in AD, now one of our 
most costly and pervasive age-related diseases. Aerobic exercise may have its greatest remediating effect 
on frontal brain regions that are most vulnerable to aging, and for glucose intolerant adults with an 
increased risk of cognitive decline and AD, to deleterious consequences of diabetes- and AD-related 
vascular dysfunction (Manschot et al., 2006; Jellinger, 2002; Stopa et al., 2008). In Williams et al., 2008 
study, exercise approaches to treatment of depression in nursing home residents with severe AD showed a 
clear benefit of the participants. The results of this study were limited due to the small sample size. There 
was evident benefit of exercise over the attention-control intervention (social conversation) on some of the 
mood outcomes. In this study the authors stated that, chair-based exercise in which non-ambulatory 
individuals could participate should be investigated and that social conversation, originally believed to be an 
attention-control, evidently had some beneficial effect although it may be necessary to provide much more 
of it than exercise to gain that effect. In Cyarto et al., 2010, concluded that the findings have the potential to 
inform practitioners about successful strategies and provide the impetus for translation into community 
programs. This study focused the participant’s cognitive, clinical symptoms, functional level and QoL but 
also on the indirect positive effects that may be experienced by the caregiver (Cyarto et al., 2010). In Baker 
et al., 2010, results showed that, six months of aerobic exercise improved cognitive performance on tasks 
of executive function including selective and divided attention, cognitive flexibility, and working memory in 
older adults with glucose intolerance. In addition, circulating levels of the AD biomarker Aβ42 tended to 
decrease for subjects in the aerobic group relative to controls.  Also in this study (Baker et al., 2010), 
executive function and insulin sensitivity of the enrolled subjects were improved with aerobic exercise, 
finding that implicates a potential benefit of improved glucose metabolism on cognitive processes. The 
results of this study suggest that aerobic exercise may also have an impact on circulating Aβ42 given that 
plasma levels tended to decrease for subjects in the aerobic exercise group relative to controls. They also 
reported a similar change in Aβ42 levels in response to a 6-month trial of aerobic exercise for older adults 
with mild cognitive impairment. Also they have stated that exercise-induced improvements in insulin 
sensitivity, cerebral blood flow, and other metabolic parameters may contribute to the observed cognitive 
benefits and that increased physical activity level is a potent non-pharmacological intervention for 
physiological symptoms associated with impaired glucose metabolism and T2DM, conditions that confer 
increased risk of AD. 
 
CONCLUSIONS & RECOMMENDATIONS 
 
Based on the reviewed studies we can say that: 
• Sharon M., 2003 study, has clearly proved that older individuals with dementia can safely participate 
in an ongoing vigorous exercise program and achieve significant physical fitness and mood gains. 
Furthermore, it demonstrated that college students are an available, safe, reliable, and affordable 
source of transportation, one-to-one exercise supervision, and companionship for elderly persons 
with dementia. 
• Exercise therapy is one of the best ways for treating AD patients and results show that exercise 
benefits are equal to medications. 
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• In future studies of exercise, inclusion of a ‘usual care’ control group must be carefully considered. 
• The results of Baker L.D et al., 2010 suggest that 6 months of moderate to high intensity aerobic 
exercise may influence circulating levels of Aβ42, a finding with potential implications for AD 
pathology. 
• Since AD patients are unlikely to start an exercise program, it is necessary that all the caregivers 
must be trained in order to encourage AD patients to exercise. 
• More research is needed to clarify the relative benefits of different types of exercise in conjunction 
with or without pharmacological intervention. 
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